Novel Molecular Scaffolds Are Broad-spectrum Antibiotics
US Application 60/707,531
Filed on 2005-08-12
Filed on 2005-08-12
The Discovery And Validation Of MDR1-inverse Agents
US Application 61/182,511
Filed on 2009-05-29
Filed on 2009-05-29
Polyphenol, Beta-Lactam, and Porphyrin Compounds as Inhibitors of TDP1 and Methods of Treating Disorders
US Application 61/268,130
Filed on 2009-06-08
Filed on 2009-06-08
INHIBITORS OF MRE11, RAD50 AND/OR NBS1
US Application 61/203,377
Filed on 2008-12-22
Filed on 2008-12-22
Inactivation Of Cbl-b Can Obviate The Requirement For CD28 Costimulation Of T Cells In Tumor Rejection
US Application 60/844,240
Filed on 2006-09-13
Filed on 2006-09-13
Oral Delivery Of Vaccines To The Large Intestine To Induce Mucosal Immunity
US Application 61/238,361
Filed on 2009-08-31
Filed on 2009-08-31
Use Of Tempol For Treatment Of Cancer
US Application 61/265,194
Filed on 2009-11-30
Filed on 2009-11-30
Cellular Noncoding MiR-1293 And MiR-608 Are Inhibitors, Respectively, For The Expression Of KSHV VIL6 And Human IL6
US Application 61/241,678
Filed on 2009-09-11
Filed on 2009-09-11
Generation And Application Of Antibodies That Bind GaLNAc1-3Gal
US Application 61/165,675
Filed on 2009-04-01
Filed on 2009-04-01
Human Monoclonal Antibody Variable Fragments (Fvs) To Mesothelin
US Application 61/162,778
Filed on 2009-03-24
Filed on 2009-03-24